Your browser doesn't support javascript.
loading
Estrogen-secreting adrenocortical carcinoma / 영남의대학술지
Article in En | WPRIM | ID: wpr-785295
Responsible library: WPRO
ABSTRACT
Adrenocortical carcinoma is a rare type of endocrine malignancy with an annual incidence of approximately 1–2 cases per million. The majority of these tumors secrete cortisol, and a few secrete aldosterone or androgen. Estrogen-secreting adrenocortical carcinomas are extremely rare, irrespective of the secretion status of other adrenocortical hormones. Here, we report the case of a 53-year-old man with a cortisol and estrogen-secreting adrenocortical carcinoma. The patient presented with gynecomastia and abdominal discomfort. Radiological assessment revealed a tumor measuring 21×15.3×12 cm localized to the retroperitoneum. A hormonal evaluation revealed increased levels of estradiol, dehydroepiandrosterone sulfate, and cortisol. The patient underwent a right adrenalectomy, and the pathological examination revealed an adrenocortical carcinoma with a Weiss' score of 6. After surgery, he was treated with adjuvant radiotherapy. Twenty-one months after treatment, the patient remains alive with no evidence of recurrence.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Recurrence / Hydrocortisone / Incidence / Adrenal Gland Neoplasms / Adrenocortical Carcinoma / Adrenalectomy / Radiotherapy, Adjuvant / Dehydroepiandrosterone Sulfate / Aldosterone / Estradiol Type of study: Incidence_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Yeungnam University Journal of Medicine Year: 2019 Type: Article
Full text: 1 Index: WPRIM Main subject: Recurrence / Hydrocortisone / Incidence / Adrenal Gland Neoplasms / Adrenocortical Carcinoma / Adrenalectomy / Radiotherapy, Adjuvant / Dehydroepiandrosterone Sulfate / Aldosterone / Estradiol Type of study: Incidence_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Yeungnam University Journal of Medicine Year: 2019 Type: Article